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Klotho is a protein of significant importance for mineral
homeostasis. It helps to increase parathyroid hormone
(PTH) secretion and in the trafficking of Naþ /Kþ -ATPase to
the cell membrane; however, it is also a cofactor for fibroblast
growth factor (FGF)-23 to interact with its receptor, FGFR1
IIIC, resulting in decreased PTH secretion. Studies on the
regulation of parathyroid klotho expression in uremia have
provided varying results. To help resolve this, we measured
klotho expression in the parathyroid and its response to
severe uremia, hyperphosphatemia, and calcitriol treatment
in the 5/6 nephrectomy rat model of secondary
hyperparathyroidism. Parathyroid klotho gene expression
and protein were significantly increased in severely uremic
hyperphosphatemic rats, but not affected by moderate
uremia and normal serum phosphorus. Calcitriol suppressed
klotho gene and protein expression in severe secondary
hyperparathyroidism, despite a further increase in plasma
phosphate. Both FGFR1 IIIC and Naþ /Kþ -ATPase gene
expression were significantly elevated in severe secondary
hyperparathyroidism. Parathyroid gland klotho expression
and the plasma calcium ion concentration were inversely
correlated. Thus, our study suggests that klotho may act
as a positive regulator of PTH expression and secretion in
secondary hyperparathyroidism.
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Klotho is a protein of significant importance for mineral
homeostasis, discovered by Kuro-o in 1997.1 Lack of klotho
in mice resembles the clinical picture of human aging.
At the same time, calcium and phosphate levels are
significantly affected and plasma levels of 1,25-dihydroxyvi-
tamin D increased.2 Klotho is highly expressed in kidney
distal convoluted tubule, choroid plexus, and parathyroid
glands.3–5
Fibroblast growth factor-23 (FGF23) is a phosphatonin
expressed in osteocytes and osteoblasts.6,7 The phenotype of
FGF23 knockout mice is similar to that of klotho knockout
mice.8,9 FGF23 and klotho act on the sodium phosphate
co-transporters NaPi2a and NaPi2c and on 1a-hydroxylase in
kidneys, and have as such a central role in phosphate and
vitamin D homeostasis.2,8 In 2006, Kurosu et al.10 showed
that klotho specifically stimulated signaling of FGF23
through the IIIC splice forms of FGF receptors (FGFRs),
most prominently FGFR1 IIIC and FGFR3 IIIC, whereas
FGFR2 IIIC and FGFR4 were of minor importance. Klotho
functions as an obligatory co-receptor for FGF23, converting
the canonical FGFRs to an FGF23-specific receptor, explain-
ing the similarities in knockout phenotypes.11–13 FGF23
reduces the amount of NaPi2a in the brush border of
proximal tubules and as such enhances renal phosphatur-
ia.9,12,14 However, the specific klotho-related mechanism in
this process has not yet been clarified.
FGF23 suppresses renal 1a-hydroxylase in the proximal
tubular cells through a klotho-mediated mechanism, whereas
FGF23/klotho-mediated induction of renal 24-hydroxylase
occurs in the distal tubules and hereby is limiting 1,25-
dihydroxyvitamin D levels.14,15 This process is klotho
dependent. Besides having activities in cooperation with
FGF23, klotho has independent effects on mineral homeostasis.
Klotho was shown to possess enzyme activity resembling
b-glucuronidase, triming sugar moieties, and stabilizing the
distal tubular epithelial calcium channel, the transient receptor
potential vanilloid 5 channel, on the cell membrane, thus
enhancing tubular reabsorption of calcium.16–18
Recently, it was discovered that klotho participates in
protein trafficking of Naþ /Kþ -ATPase to the cell membrane
in the choroid plexus and parathyroid cells. In parathyroids
it has been suggested that low extracellular calcium
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level enhances trafficking of Naþ /Kþ -ATPase to the cell
surface and thereby increases parathyroid hormone (PTH)
secretion.19
Another effect of klotho in the parathyroid cell might be
related to its function as co-receptor for FGF23. FGF23
suppresses the expression and secretion of PTH in in vivo and
in vitro models.4,20 When a stable form of FGF23, FGF23
R176Q, was injected into rats, PTH gene expression was
suppressed putatively in the presence of klotho.4,20 As such in
parathyroids klotho might have pleiotropic effects some
dependent upon FGF23 and others not. These effects might
even be opposite as FGFR-associated klotho might contribute
to suppression of PTH secretion whereas Naþ /Kþ -ATPase-
associated klotho might contribute to an increase of PTH
secretion.19,21 Therefore, in parathyroids, klotho seems to be
able to convey both negative and positive signals to PTH
regulation.
Studies on regulation of parathyroid klotho expression in
uremia have provided varying results. Thus, expression of
klotho in parathyroid glands of rats with mild uremia and
normal to slightly elevated PTH was not significantly
changed.22 In rats with more severe uremia parathyroid,
klotho expression was significantly increased after 2 weeks
of uremia and then the expression was suppressed at 6 weeks
of uremia, using an adenine uremic rat model in a study
by Galitzer et al.23 In human uremic parathyroid glands, it
has been found that expression of klotho was significantly
decreased24,25 or increased, varying in the different
parathyroid nodules.26 Severe uremia and secondary hyper-
parathyroidism (sec. HPT) are characterized by hyperpho-
sphatemia and hypocalcemia. The aim of this investigation
therefore was further to examine parathyroid expression of
klotho, and at the same time the expression of receptors for
FGF23 and Naþ /Kþ -ATPase (ATP1a1) in response to severe
chronic uremia, high levels of phosphate, and administration
of high doses of calcitriol.
RESULTS
Biochemical characteristics of sham-operated,
5/6 nephrectomized, and calcitriol-treated rats
Biochemical findings of sham-operated rats, uremic rats on a
standard diet, and uremic rats kept on a high-phosphate
(HP) diet are shown in Table 1, whereas the results of
sham-operated and uremic HP (UHP) rats receiving
either 200 ng of calcitriol or vehicle are presented in Table 2.
5/6 Nephrectomy induced a significant increase in plasma
urea, creatinine, and PTH levels. In UHP rats, severe
hypocalcemia, hyperphosphatemia, and very severe hyper-
parathyroidism were induced (PTH increased from 43±6
to 1848±150 pg/ml, Po0.005). Plasma FGF23 levels were,
as expected, severely increased in uremic rats. Calcitriol
treatment of uremic rats resulted in amelioration of
hypocalcemia, a significant suppression of PTH levels and
further increase in FGF23 and phosphate levels. As a result of
calcitriol treatment sham-operated rats also had significantly
suppressed PTH levels, together with increased p-Ca2þ and
FGF23 levels.
Effect of uremia and HP diet on parathyroid expressions
of klotho, ATP1a1, PTH, CaR, VDR genes and proteins
Figure 1 shows results of assessment of gene activity in
parathyroid glands by real-time PCR in sham, moderately
uremic rats on standard diet (U) and in the UHP groups.
Mean gene expression of the sham group was set to 1. The
relative gene expressions of uremic group were not affected,
whereas the UHP group was characterized by a significantly
Table 1 | Plasma values of sham and uremic rats
N p-PTH (pg/ml) p-Phosphate (mM) p-Ca2+ (mM) p-Creatinine (lM) p-Urea (mM)
Sham 19 43±6 1.65±0.08 1.28±0.01 39±1 6±0.3
Uremic 8 198±246w 1.40±0.46 1.28±0.06 123±30** 21±5**
Uremic HP 32 1848±150** 4.54±0.40** 0.85±0.04** 165±13** 35±4**
Abbreviations: HP, high phosphate; PTH, parathyroid hormone.
Significance of sham versus uremic groups.
wPo0.01, **Po0.005.
Table 2 | Plasma values of sham and uremic HP rats given vehicle (V) or 200ng of calcitriol (C)
N p-PTH (pg/ml) p-Phosphate (mM) p-Ca2+ (mM) p-Creatinine (lM) p-Urea (mM) p-FGF23 (pg/ml)
Sham+V 9 44±8 1.96±0.01 1.28±0.03 35±1 7±0.2 300±17
Sham+C 10 7±5** 2.72±0.07w 1.39±0.01y 44±2w 7±0.2 2079±103**
Uremic HP+V 10 1475±162 3.20±0.27 0.99±0.05 115±12 22±2 2073±404
Uremic HP+C 11 701±201w 4.56±0.73 1.15±0.05y 152±32 34±8w 14242±2615**
Abbreviations: FGF, fibroblast growth factor; HP, high phosphate; PTH, parathyroid hormone.
Significant differences of the effects of calcitriol versus vehicle are indicated in the sham as well as the uremic HP groups.
yPo0.05, wPo0.01, **Po0.005.
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increased expression of PTH to 2.11±0.11 (Po0.005),
a significant decrease of VDR to 0.24±0.06 (Po0.005),
and a significant decrease of CaR to 0.83±0.03 (Po0.05).
Expression of klotho was significantly increased, 1.34±0.07
(Po0.01) and expression of ATP1a1, a functional subunit of
the Naþ /Kþ -ATPase, was also significantly increased to
1.61±0.09 (Po0.005). In parathyroids of UHP rats, the
protein expressions of klotho and the Naþ /Kþ -ATPase were
significantly elevated, (Po0.01), as shown in Figure 2a,
whereas, as expected, protein expression of VDR was
significantly suppressed (Po0.005).
Parathyroid expressions of FGFR1–FGFR4 genes
Klotho has been shown to be a cofactor to various FGFRs
forming a specific receptor for FGF23 signaling.10 Figure 3
shows the relative expressions of different FGFRs in rat
parathyroids (note the logarithmic scale on the ordinate).
Thus, FGFR1 and splice variant FGFR1 IIIC were highly
expressed, whereas expression of FGFR3 and FGFR4 was
minimal. FGFR2 was highly expressed as well, but its
relevance for FGF23 signaling is uncertain.
Effect of uremia and HP diet on parathyroid expressions
of FGFR1–FGFR4 genes
Figure 4 shows the effect of uremia HP on parathyroids
expression of four different FGFRs, as well as the special IIIC
splice variants of FGFR1 and FGFR3. Compared to the sham-
operated group, significantly higher expression in the UHP
group was found for FGFR1 IIIC to 1.41±0.07 (Po0.005)
and FGFR2 gene to 1.76±0.12 (Po0.005). Total FGFR1 was
not affected in uremia and expression of FGFR3 was
significantly suppressed in the UHP group to 0.49±0.04
(Po0.005), whereas FGFR3 IIIC expression was the same
between the groups, 0.98±0.08. FGFR4 is not spliced in the
IIIC version, and therefore only total FGFR4 gene activity was
measured and found to be significantly suppressed to
0.65±0.06 (Po0.005) in the UHP group.
Effect of calcitriol on parathyroid klotho and ATP1a1 genes as
compared to the corresponding effect on PTH, CaR, and VDR
gene expressions in normal and uremic rats on an HP diet
In kidneys, klotho is highly expressed in the distal convoluted
tubule, where it has a negative feedback effect on synthesis of
calcitriol. Expression of klotho is activated by calcitriol in a
time-dependent manner and suppresses CYP27b encoding
the 25-(OH)vitamin D 1a-hydroxylase. To examine whether
calcitriol also activates expression of klotho gene in
parathyroid glands, we injected increasing doses of calcitriol
or vehicle intraperitoneally into normal rats, as shown in
Figure 5. As expected, a significant decrease of PTH and a
significant dose-related increase of both CaR and VDR gene
expressions were found in parathyroids of the group
receiving calcitriol. Parathyroid gene expressions of klotho
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Figure 1 | Effect of uremia (U) and uremia and high-phosphate
diet (UHP) on parathyroid gene expressions, compared to a
sham group (S). Klotho and Naþ /Kþ -ATPase were significantly
elevated in the UHP group. CaR, calcium sensing receptor gene;
VDR, vitamin D receptor gene; PTH, parathyroid hormone gene;
ATP1a1, Naþ /Kþ -ATPase a 1 subunit gene. *Po0.05, **Po0.01,
***Po0.005.
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Figure 2 | Expression of klotho protein in parathyroids of
normal and uremic rats. Effects of calcitriol. (a) Western blots on
the expression of klotho, Naþ /Kþ -ATPase (NaK), and vitamin D
receptor (VDR) proteins in the parathyroids from three
representative uremic high-phosphate (HP) and normal rats, using
B2M as control protein. Both klotho and NaK were significantly
upregulated at the protein level in the parathyroids from uremic
HP rats, whereas the expression of VDR was significantly
suppressed. (b) Effect of a single dose of 200 ng of calcitriol.
Western blots on the expression of klotho and VDR proteins in the
parathyroids from three representative uremic HP and normal
rats, showing a significant downregulation of klotho and
upregulation of VDR after calcitriol. (c) Quantification of the klotho
protein expression in the uremic parathyroids and after calcitriol.
*Po0.05, **Po0.01.
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and ATP1a1 were however not significantly affected by
calcitriol in these normal rats.
Figure 6 shows effect of a single injection of 200 ng of
calcitriol on parathyroid gene expressions in uremic hyper-
phosphatemic rats. Calcitriol administration resulted in a
significant suppression by 22% (Po0.05) of the klotho gene
in uremic parathyroid glands and by 38% at the klotho
protein level (Po0.05; Figure 2b and c). Expression of
ATP1a1 was not significantly affected by calcitriol, whereas
the well-known effects of calcitriol on parathyroid PTH, CaR,
and VDR gene expressions were seen (Figure 6).
Parathyroid klotho correlations in uremia
In UHP rats, a significant inverse correlation was shown
between parathyroid klotho gene expression and p-Ca2þ
(r¼0.62, Po0.005), and between p-Ca2þ and parathyroid
FGFR1 IIIC mRNA gene expression (r¼0.85, Po0.0001,
Figure 7).
Figure 8 shows highly significant direct correlations between
klotho and PTH gene expressions (r¼ 0.78, Po0.0001); FGFR1
IIIC and PTH gene (r¼ 0.90, Po0.0001); and klotho and
FGFR1 IIIC gene expressions (r¼ 0.71, Po0.0001) in para-
thyroids of UHP rats with severe sec. HPT. Linear correlations
were shown between ATP1a1 and PTH gene (r¼ 0.72,
Po0.0001) and ATP1a1 and klotho gene expressions (r¼ 0.78,
Po0.0001) in uremic parathyroids (Figure 9).
DISCUSSION
Sec. HPT in uremic rats, kept on a high-phosphorus diet, was
in this study associated with a significantly increased
expression of parathyroid klotho gene and protein. Other
studies on parathyroid klotho expression in uremia have
provided varying results. Thus, expression of klotho in
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Figure 3 | The expressions of the different fibroblast growth
factor (FGF) receptors in the rat parathyroids are presented in
relation to the expression of FGFR1, which is set to 1. Please
note that the ordinate is a logarithmic scale. Thus, FGFR1 and the
splice variant FGFR1 IIIC are highly expressed, whereas the
expressions of FGFR3 and FGFR4 are minimal. FGFR2 is highly
expressed as well, but its relevance for FGF23 signaling is
uncertain.
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Figure 4 | Effect of uremia and high-phosphate diet (UHP)
on the parathyroid gene expressions of fibroblast growth
factor receptors (FGFRs) compared to a sham group (S). IIIC
depicts the ‘C’ splice variants of FGFR1 and FGFR3. ***Po0.005.
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Figure 5 | Effect of increasing doses of calcitriol on
parathyroid gene expressions in normal rats. No effect was
found on klotho and Naþ /Kþ -ATPase, whereas dose-dependent
effects were found on CaR, VDR, and PTH, as expected. CaR,
calcium sensing receptor gene; VDR, vitamin D receptor gene;
PTH, parathyroid hormone gene; klotho, klotho gene; ATP1a1,
Naþ /Kþ -ATPase a 1 subunit gene. **Po0.01, ***Po0.005.
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Figure 6 | Effect of a single dose of 200ng of calcitriol or
vehicle on parathyroid gene expressions in uremic rats on a
high-phosphate diet (UHP) compared to a vehicle-treated
sham group (S). Calcitriol significantly reduced the elevated
expression of klotho in the UHP group and had the expected
effects on CaR, VDR, and PTH, whereas Naþ /Kþ -ATPase was not
affected. CaR, calcium sensing receptor gene; VDR, vitamin D
receptor gene; PTH, parathyroid hormone gene; klotho, klotho
gene; ATP1a1, Naþ /Kþ -ATPase a 1 subunit gene. *Po0.05,
**Po0.01 (between UHP and UHPþC).
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parathyroid glands of rats with mild uremia and normal to
slightly elevated PTH levels was not significantly different
from that of normal rats.22 In rats with more severe uremia
parathyroid klotho expression was significantly increased
after 2 weeks of uremia and then the expression was found to
be suppressed at 6 weeks of uremia, as shown by Galitzer
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Figure 7 | Linear correlations between gene expression of klotho and plasma Ca2þ (r¼0.80, Po0.0001) and fibroblast growth
factor receptor 1 (FGFR1) IIIC and plasma Ca2þ (r¼0.86, Po0.0001) in the parathyroids of uremic high-phosphate (HP) rats with
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Figure 8 | Linear correlations between gene expression of klotho and parathyroid hormone (PTH) (r¼ 0.78, Po0.0001); fibroblast
growth factor receptor 1 (FGFR1) IIIC and PTH (r¼ 0.90, Po0.0001); and klotho and FGFR1 IIIC (r¼ 0.71, Po0.0001) in the
parathyroids of uremic high-phosphate (HP) rats with severe hyperparathyroidism.
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Figure 9 | Linear correlations between gene expressions of Naþ /Kþ -ATPase a 1 (ATP1a1) and parathyroid hormone (PTH) (r¼ 0.72,
Po0.0001) and ATP1a1 and klotho (r¼ 0.78, Po0.0001) in the parathyroids of uremic high-phosphate (HP) rats with severe
hyperparathyroidism.
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et al.,23 using an adenine uremic rat model. In a study on
human uremic parathyroid glands, Komaba et al.25 found
that the expression of klotho was significantly depressed, and
similar results were published by Kumata et al.,24 whereas
Ohkido et al.26 described elevated expression of klotho by
immunostaining that had a varying degree in different
nodules of uremic hyperplastic parathyroid glands.
However, in parathyroid adenomas from patients with
primary hyperparathyroidism a decreased level of klotho
protein has been found27 and an inactivating mutation in the
klotho gene resulted in a human phenotype of severe
hyperparathyroidism with elevated PTH in the presence of
hypercalcemia.28 As such an enhanced or normal expression
of klotho in our rat models is surprising.
Furthermore, resistance to the suppressive action of
FGF23 on the expression of PTH gene and on PTH secretion
would be expected in uremia,29 as the uremic condition is
associated with stimulated PTH gene activity and PTH
secretion, despite extremely elevated FGF23 levels. Such a
resistance could potentially be mediated through suppressed
expression of the specific FGFR for FGF23 and of klotho as
an obligatory co-receptor. In this study, however, both the
expression of klotho and FGFR1 IIIC receptor genes were
significantly enhanced. We performed three independent sets
of investigations and each time the same elevated expression
of klotho gene and protein and expression of FGFR gene was
found. In this respect it is important, as pointed out by
Ohkido et al.,26 to remember the difference between severe
human hyperparathyroidism with nodular formation, where
different nodules might have completely different expression
of, for example, PTH and PTHrP,30 whereas the rat uremic
model reflects pure, but severe parathyroid diffuse hyperpla-
sia, and as such represents a more uniform picture of the
abnormalities.
Differences in experimental models, 5/6 nephrectomy, and
HP diet against the adenine model might have contributed to
different expressions of klotho.
The regulatory mechanism of calcitriol synthesis in
kidneys is positively controlled by PTH and negatively
controlled by klotho, acting on the 25(OH)-vitamin D-1a
hydroxylase gene.8 Calcitriol closes the negative feedback
loop by positively controlling klotho gene expression in
kidneys. As klotho gene and protein are expressed in
parathyroid glands, we examined whether calcitriol also
activates klotho gene expression in this tissue. First, in normal
rats we injected either vehicle or a dose of 200 or 4000 ng of
calcitriol, intraperitoneally, and measured the effect on PTH,
CaR, VDR, klotho, and ATP1a1 gene activity after 24 h. The
well-known effects of calcitriol were observed,31 with
significantly suppressed PTH gene activity and significantly
increased CaR and VDR gene activities,32,33 as shown in
Figure 5. These effects were dose dependent. Although
calcitriol had effects on PTH, CaR, and VDR gene activity, no
significant effect was found in normal rats on parathyroid
klotho gene activity, even at very high doses of calcitriol. As
such, in contrast to what previously has been shown in the
kidneys, no stimulatory effect was found in the parathyroids
of calcitriol on klotho gene expression. These results point
toward a tissue-specific regulation of klotho gene by calcitriol.
The results of this investigation clearly showed that
parathyroid klotho was not elevated in mild to moderate
uremia. In severe uremia with severe hyperparathyroidism
combined with hyperphosphatemia and hypocalcemia, para-
thyroid klotho mRNA and protein were significantly elevated
in this experimental model. The elevated klotho levels were
however clearly reduced by treatment with calcitriol, despite
a further increase in plasma phosphate, suggesting that
phosphate levels are not responsible for the changes on
klotho expression in uremic parathyroids. The concomitant
normalization of plasma Ca2þ and CaR expression in
parathyroid glands due to calcitriol might have contributed
to the downregulation of klotho. The final answer to this
question might need in vitro studies.
Previous investigations on the parathyroids have shown
that FGF23 suppressed PTH expression in vivo as well as
in vitro,20 and at the same time increased klotho protein
levels.4,5 It is well known that FGF23 levels are highly
increased in the later stages of chronic kidney disease.34,35
Elevated FGF23 levels might stimulate the parathyroid klotho
gene expression, as seen in this study, where a sixfold increase
in plasma FGF23 levels was observed in uremic rats on an HP
diet (see Table 2). PTH levels were also highly elevated.
Therefore, the expression of four different fibroblast growth
factor receptors (FGFR1–FGFR4) was examined. These
receptors differ from one another in their ligand affinities
and tissue distribution.36 As shown in Figure 4, sec. HPT and
severe uremia significantly affected the expression of the
FGFR genes. Kurosu and co-workers identified FGFR1 IIIC
and FGFR3 IIIC as the major receptors for the specific
binding of FGF23 and ability to convey a signal into the cell,
whereas FGFR2 IIIC and FGFR4 only to a smaller degree
bound FGF23.10,37 FGFR1 IIIC was significantly upregulated
in the UHP group as compared to sham-operated rats,
whereas the expression of FGFR3 IIIC was similar to that of
sham-operated rats.
The question therefore is how high levels of PTH can
persist under very high levels of its own suppressor, FGF23,
and high levels of the suppressors receptor and co-receptor
(FGFR1 IIIC and klotho). One theoretical explanation could
be that the reduced expression and activation of the calcium
sensing receptor and hyperphosphatemia in the uremic
setting oppose the suppressive effect of FGF23 on PTH gene
expression and PTH secretion. Alternatively, FGF23 might
have dual effects on the parathyroids such that the
stimulatory effect on parathyroid klotho expression can
activate another mechanism, which is promoting PTH
secretion. At present, however, in the uremic setting the
resistance toward FGF23 signaling in the parathyroid glands
remains unexplained and similarly is the role of klotho in the
uremic parathyroids not fully clarified.
Brown E showed in 1983 that ouabain by blocking the
Naþ /Kþ -ATPase activity could suppress PTH secretion
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in vitro.38 Recently, Imura and co-workers proposed the
existence of a signaling pathway between the Naþ /Kþ -
ATPase and increased PTH secretion in vivo.19,21 In the
present UHP group, it was found that the ATP1a1 gene
encoding the a subunit of the Naþ /Kþ -ATPase was
significantly upregulated together with an elevated expression
of klotho, as shown in Figure 1. These findings correlated with
the increased need to raise plasma PTH in response to
uremia.
Klotho might have a pivotal role in both the positive and
negative signaling on PTH gene expression and secretion. It
has been shown that FGF23 has suppressive effect on PTH
secretion4,20 and that the effect of the Naþ /Kþ -ATPase
activity is to increase PTH secretion.19 It is therefore puzzling
that both pathways are upregulated in a setting, where
increased levels of PTH are required.
Thus, in this model on uremia with severe sec. HPT
associated with hyperphosphatemia, hypocalcemia, and
highly elevated levels of plasma PTH, high levels of plasma
FGF23 together with increased parathyroid expression of the
FGFR1 IIIC gene and high expression of parathyroid klotho
and ATP1a1 were found.
However, despite normal or high mRNA and protein
concentrations post-receptor disturbances (for example, for
klotho and FGFRs) or unforeseen decreases in activity (for
example, for Naþ /Kþ -ATPase) could be responsible for the
observed apparent resistance of the parathyroid gland to the
extremely high serum FGF23 concentrations associated with
severe uremia.
The levels of plasma calcium might be of importance for
klotho expression. As such decreasing klotho expression in
the parathyroids of patients with primary hyperparathyroid-
ism correlated with increasing plasma ionized calcium.27 A
similar significant negative correlation between the expres-
sion of klotho gene and plasma Ca2þ was found in the UHP
group of this investigation, as shown in Figure 7. Therefore,
low-ionized calcium might be permissive for an increase in
klotho expression. Furthermore, a significant positive correla-
tion was found between klotho and ATP1a1 (Figure 9). As
such these findings support the work by Imura et al.,19 which
showed that klotho and the Naþ /Kþ -ATPase act as positive
regulators of PTH secretion. In accordance with that PTH
gene expression correlated significantly with the gene
expressions of klotho as well as of ATP1a1 in this investigation
(Figures 8 and 9).
In conclusion, the results of this study clearly showed that
the expression of parathyroid klotho gene and protein was
significantly increased in an experimental model of severe
uremia, combined with severe sec. HPT and characterized by
pronounced hyperphosphatemia and hypocalcemia. Para-
thyroid klotho was not elevated in uremic rats with normal
plasma phosphate and ionized calcium. Calcitriol treatment
suppressed the parathyroid expression of klotho in severe
uremia, despite a further increase in plasma phosphate,
whereas calcitriol had no effect on klotho expression in
parathyroids of normal rats. In uremia the elevated expres-
sion of the parathyroid klotho gene was reduced again, when
calcium levels became normalized. The expression of the
specific FGF23 receptor, the FGFR1 IIIC gene, and Naþ /Kþ -
ATPase gene was similarly significantly increased in the
uremic parathyroids. Klotho gene and protein expression
correlated significantly with PTH gene expression, indicating
a potential new role of klotho on PTH signaling in the
parathyroids, where klotho may act as a positive regulator of
PTH expression and secretion in the model of severe, sec.
HPT in uremic rats.
MATERIALS AND METHODS
Animals
The experimental studies were performed in accordance with the
Danish law and approved by Ministry of Justice. Adult male
Wistar rats, 250 g (Taconic A/S, Ejby, Denmark), were fed a standard
diet (0.9% calcium, 0.7% phosphorus, and vitamin D, 1000 IU/kg)
or an HP diet (0.9% calcium, 1.2% phosphorus, and vitamin D,
1000 IU/kg) with free access to food and water.
5/6 Nephrectomy
Chronic renal failure was induced by one-step 5/6 nephrectomy.39
One group was given a standard diet. To induce severe HPT, we gave
HP diet to another group. Duration of uremia was 8 weeks. The rats
received anesthesia with hypnorm/midazolam, 200 ml/100 g rat
subcutaneously. Buprenorfin (0.3mg/ml, at a dose of 200ml per
rat; Schering-Plough, Copenhagen, Denmark) and rimadyl (50mg/
ml, at a dose of 30ml per rat) were used as pain relief.
Parathyroidectomy
Parathyroid glands were removed by microsurgery and frozen in
liquid nitrogen.
Effect of uremia
Uremic rats were fed either a standard diet (n¼ 8) or an HP diet
(n¼ 32) for 8 weeks and then killed. Parathyroids were obtained for
analysis of gene activity and protein determination. Nineteen sham-
operated rats were examined.
Effect of calcitriol
The effect of calcitriol (Leo Pharma, Ballerup, Denmark) was first
examined in normal rats by intraperitoneal injection of increasing
doses: 0, 200, or 4000 ng. Parathyroids were harvested after 24 h.
Next, effect of a single dose of 200 ng of calcitriol or vehicle was
assessed in UHP rats (n¼ 10) and compared to sham-operated rats
(n¼ 9) and parathyroids harvested after 24 h.
Plasma determinations
Plasma phosphate, urea, and creatinine were analyzed by Vitros 250
(Ortho-Clinical Diagnostics, Raritan, NJ, USA); Ca2þ by ABL 505
(Radiometer, Copenhagen, Denmark); and FGF23 by a human FGF-
23 ELISA kit (Kainos Laboratories, Tokyo, Japan), measuring full-
length FGF23 and PTH by a rat bioactive intact PTH ELISA assay
(Immunotopics, San Clemente, CA, USA).
RNA isolation and reverse transcription–PCR
Total RNA of parathyroid glands was extracted with TRIzol (Sigma-
Aldrich, St Louis, MO, USA). First-strand cDNA was synthesized
from 0.5 mg of RNA with Superscript III cDNA kit (Invitrogen,
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Carlsbad, CA, USA). Lightcycler 480 II (Roche, Basel, Switzerland)
and Stratagene Brilliant II SYBR kit (Stratagene, La Jolla, CA, USA)
were used for quantitative real-time PCR. Primers are listed in
Table 3. All samples were run in duplicate. PCR product was
confirmed on 2% agarose gels. Gene activity was normalized to the
mean of three different housekeeping genes (ARBP, B2M, and
EEF1a).
Western blot analysis
Total protein (12mg) was separated by 7.5% SDS–polyacrylamide gel
electrophoresis (Bio-Rad, Copenhagen, Denmark; cat. no. 161-1172)
and transferred onto nitrocellulose membranes (Thermo Scientific,
Bonn, Germany; cat. no. 88013). Membranes were blocked with 5%
milk in TBST buffer before incubation with the primary antibody
overnight at 41C.
Antibodies used were Klotho KM2076 (1:6000), kindly donated by
Kyowa Hakko Kirin, Pharmacological Research Laboratories (Hisashi
Hasegawa, Japan), and anti-rat Dako P0450 secondary antibody
(1:1000; Dako, Glostrup, Denmark); Naþ /Kþ -ATPase (1:1000, cat.
no. sc-28800) and anti-rabbit Dako P0448 secondary antibody
(1:2000); VDR (1:1000, cat. no. sc-1008; Santa Cruz Biotechnology,
Santa Cruz, CA, USA) and anti-rabbit Dako P0448 secondary
antibody (1:2000); B2M (1:1000, cat. no. sc-15366; Santa Cruz) and
anti-rabbit Dako P0448 secondary antibody (1:2000).
Statistic calculations
Student’s t-test or Mann–Whitney test were used and data are
presented as mean±standard error of the mean (s.e.m.). Po0.05
was considered statistically significant.
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